Warenkorb
Kostenloser Versand
Unsere Operationen sind klimaneutral

Antibodies for Treating Cancer Melvyn Little

Antibodies for Treating Cancer von Melvyn Little

Antibodies for Treating Cancer Melvyn Little


105.00
Zustand - Wie Neu
Nur noch 1

Zusammenfassung

This book presents a compact overview of the history, evolution and fascinating novel applications of antibodies for the treatment of cancer, leading the reader step by step to the latest advances.

Antibodies for Treating Cancer Zusammenfassung

Antibodies for Treating Cancer: Basics, Development, and Applications Melvyn Little

This book presents a compact overview of the history, evolution and fascinating novel applicationsof antibodiesfor the treatment of cancer, leading the reader step by step to the latest advances. Interesting anecdotes, together with self-explanatory and clearly structured figures with a humorous touch, facilitate the readers understanding of this complex topic. Clinical cases round out the book, making it a valuable aid for professionals in their everyday practice.

The growing importance of the topics covered here was highlighted by the joint award of the 2018 Nobel Prize in Chemistry to Frances H. Arnold (directed evolution of enzymes), George P. Smith (phage display of peptides) and Sir Gregory P. Winter (phage display of antibodies).Furthermore, the 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. Many of the antibodies that are now being brought to market target precisely these immune checkpoint modulators.

The book addresses a broad readership, ranging from professionals and experts in the field to residents and medical students.

Über Melvyn Little

Melvyn Little received his degree in chemistry and PhD in biochemistry fromBangor University, Walesand subsequently completed a Postdoc at the Max-Planck-Institute for Cell Biology in Wilhelmshaven, Germany. He has served as head of the Research Group Recombinant Antibodies at the German Cancer Research Center in Heidelberg and as an External Professor of Biochemistry at Heidelberg University.

In addition, he was a Co-founder and Supervisory Board Member of thebiotech firm Affitech in Oslo, Norway, as well as Founder and Management Board Member of the biotech firmAffimedin Heidelberg.

His primary research interest is in the development of dual binding antibodies for recruiting killer immune cells to destroy tumor cells. Currently he is in retirement and a biotechnology consultant.

Inhaltsverzeichnis

1 Life-saving antibodies history of immunization.- 2 Current approaches for immunising against cancer.- 3 Function and Structure of antibodies.- 4 Of mice and men - production of therapeutic antibodies.- 5 Novel modular antibodies.- 6 Antibodies as Magic Bullets.- 7 Mediation of tumor cell destruction.- 8 Engagement of immune killer cells.- 9 Approved antibodies for cancer therapy.- 10 Bringing therapeutic antibodies on the market.- 11 Future developments outlook.

Zusätzliche Informationen

GOR013864814
9783030726010
3030726010
Antibodies for Treating Cancer: Basics, Development, and Applications Melvyn Little
Gebraucht - Wie Neu
Broschiert
Springer Nature Switzerland AG
2022-05-12
151
N/A
Die Abbildung des Buches dient nur Illustrationszwecken, die tatsächliche Bindung, das Cover und die Auflage können sich davon unterscheiden.
Das Buch wurde gelesen, ist aber in gutem Zustand. Alle Seiten sind intakt, der Einband ist unversehrt. Leichte Gebrauchsspuren am Buchrücken. Das Buch wurde gelesen, sieht jedoch noch wie neu aus. Der Bucheinband weist keine sichtbaren Gebrauchsspuren auf. Gegebenenfalls ist auch ein Schutzumschlag verfügbar. Keine fehlenden oder beschädigten Seiten, keine Risse, eventuell minimale Knicke, keine unterstrichenen oder markierten Textstellen, keine beschrifteten Ränder.